Cytokine production at the site of disease in chronic eosinophilic pneumonitis

被引:34
作者
Kita, H
Sur, S
Hunt, LW
Edell, ES
Weiler, DA
Swanson, MC
Samsel, RW
Abrams, JS
Gleich, GJ
机构
[1] MAYO CLIN & MAYO FDN, DEPT MED, ROCHESTER, MN 55905 USA
[2] UNIV CHICAGO HOSP, DEPT MED, CHICAGO, IL USA
[3] DNAX RES INST MOLEC & CELLULAR BIOL INC, PALO ALTO, CA 94304 USA
关键词
D O I
10.1164/ajrccm.153.4.8616578
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Chronic eosinophilic pneumonitis (CEP) is characterized by longstanding respiratory symptoms accompanied by a massive pulmonary eosinophil infiltration. We hypothesized that cytokine(s) produced in the disease sites are implicated in the pathophysiology of CEP. We studied peripheral blood and bronchoalveolar lavage fluids (BALE) obtained from two lung segments of a patient with CEP. Seventy times more eosinophils were found in the BALF from an involved lung segment (showing patchy opacification on a chest roentgenogram) than from an uninvolved segment. The eosinophil-active cytokines interleukin-5 (IL-5), IL-6, and IL-10 were strikingly elevated in the BALF from the involved lung segment, whereas no or minimal levels of these cytokines were detectable in the BALE from the uninvolved segment or serum, respectively. Leukocytes in the involved lung segment, but not those in peripheral blood, expressed messenger ribonucleic acid (mRNA) for IL-5, IL-6, and IL-10. In contrast, IL-2, IL-3, IL-4, interferon-gamma (IFN-gamma), granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-alpha) were not detected in any sample. These findings suggest that increased production of several cytokines, such as IL-5, IL-6, and IL-10, in the involved lung segment, but not in the uninvolved lung segment or peripheral blood, is a critical pathophysiologic feature of CEP.
引用
收藏
页码:1437 / 1441
页数:5
相关论文
共 26 条
[1]   CHRONIC EOSINOPHILIC PNEUMONIA [J].
CARRINGT.CB ;
ADDINGTO.WW ;
GOFF, AM ;
MADOFF, IM ;
MARKS, A ;
SCHWABER, JR ;
GAENSLER, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (15) :787-&
[2]  
EBISAWA M, 1994, J IMMUNOL, V152, P4590
[3]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[4]  
GAENSLER EA, 1977, AM J ROENTGENOL, V128, P1
[5]   ULTRASTRUCTURAL AND IMMUNOHISTOCHEMICAL EVIDENCE FOR RELEASE OF EOSINOPHILIC GRANULES INVIVO - CYTOTOXIC POTENTIAL IN CHRONIC EOSINOPHILIC PNEUMONIA [J].
GONZALEZ, EB ;
SWEDO, JL ;
RAJARAMAN, S ;
DANIELS, JC ;
GRANT, JA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (05) :755-762
[6]  
HAMID Q, 1992, BLOOD, V80, P1496
[7]   AN IMPROVED IMMUNOMAGNETIC PROCEDURE FOR THE ISOLATION OF HIGHLY PURIFIED HUMAN BLOOD EOSINOPHILS [J].
HANSEL, TT ;
DEVRIES, IJM ;
IFF, T ;
RIHS, S ;
WANDZILAK, M ;
BETZ, S ;
BLASER, K ;
WALKER, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 145 (1-2) :105-110
[8]   CHRONIC EOSINOPHILIC PNEUMONIA - A REPORT OF 19 CASES AND A REVIEW OF THE LITERATURE [J].
JEDERLINIC, PJ ;
SICILIAN, L ;
GAENSLER, EA .
MEDICINE, 1988, 67 (03) :154-162
[9]   INTERLEUKIN-10-DEFICIENT MICE DEVELOP CHRONIC ENTEROCOLITIS [J].
KUHN, R ;
LOHLER, J ;
RENNICK, D ;
RAJEWSKY, K ;
MULLER, W .
CELL, 1993, 75 (02) :263-274
[10]   RECOMBINANT HUMAN INTERLEUKIN-5 IS A SELECTIVE ACTIVATOR OF HUMAN EOSINOPHIL FUNCTION [J].
LOPEZ, AF ;
SANDERSON, CJ ;
GAMBLE, JR ;
CAMPBELL, HD ;
YOUNG, IG ;
VADAS, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (01) :219-224